Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at TroVax for advanced kidney cancer (TRIST)

Overview

Cancer types:

Kidney cancer, Renal cell cancer

Status:

Results

Phase:

Phase 3

Details

This trial was looking at the combination of standard treatment and a vaccine called TroVax for advanced kidney cancer (renal cell cancer).

Recruitment start: 19 February 2007

Recruitment end: 11 April 2008

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor R Hawkins

Supported by

Experimental Cancer Medicine Centre (ECMC)

National Institute for Health Research Cancer Research Network (NCRN)

Oxford Biomedica

Last reviewed: 17 Aug 2016

CRUK internal database number: 899

Help and support